Intra-cavitary brachytherapy in endometrial carcinoma: experience with cobalt-60 source.

Purpose: To report vaginal cuff brachytherapy (VCB) dosimetry parameters and clinical outcomes of patients with localized endometrial cancer treated with adjuvant high-dose-rate (HDR) brachytherapy using a cobalt-60 (Co) source.

Material And Methods: Between 2011 and 2017, we identified patients with endometrial cancer treated with surgery and adjuvant VCB. Dosimetry variables analyzed included D, D, and D for organs at risk (OARs) and distance from cylinder surface to 150% and 200% isodose line in vaginal mucosa.